Carcinoid NETs

カルチノイド癌と神経内分泌腫瘍のためのセルフケア。

Developed in partnership with the Carcinoid Cancer Foundation (CCF), this app makes it easy to record your symptoms, nutritional concerns, moods, set up medication reminders, and more. Choose what you want to track to build your own summary “My Storylines” to learn more about your health, and to share more – safely and securely – with your doctor about what happened between visits.

Choose from the following health tools to help you better manage and monitor carcinoid cancer and neuroendocrine tumors (NETs), including pancreatic NETs – whether you are just diagnosed, on active treatment, or on surveillance:

MEDICATION REMINDER

Taking your prescribed medications on schedule is an essential part of overall self-care. Keep your mind at ease by receiving reminders for taking your medications on your mobile device.

RECORD FOOD REACTIONS

Document what foods may be triggering symptoms such as flushing or diarrhea. This helps you choose and adjust to the right foods, which may be helpful to give you better control over your symptoms.

DAILY MOODS AND JOURNAL

Track and understand your emotions and what might be driving them. Keep a journal as it has been shown to increase wellbeing.

SYNC A DEVICE

Import data from other health and fitness apps that you use.

SHARE YOUR STORY

Every captured event is summarized in a simple view called “My Storylines.” Choose what you want to track, and choose what you want to share with your care team or your loved ones.

By using Carcinoid NETs Health Storylines, you have the opportunity to anonymously contribute learning from your story to a vital data resource that the healthcare industry can use to improve care in the future, for people like you.

Carcinoid NETs Health Storylines is developed in partnership with the Carcinoid Cancer Foundation, and is powered by the Health Storylines™ platform from Self Care Catalysts Inc.

Disclaimer: App only contains medication database for US and Canada at this time. Other countries medication databases coming soon.